Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Medical Innovation Will Not Be “Taxed Away”

June 18, 2013 4:43 pm | by Sean Fenske, Editor-in-Chief, MDT | Blogs | Comments

“Take two and call me in the morning.” That’s the phrase that came to mind while preparing a particular article recently. While “Coating for Consumption” doesn’t deal with taking two pills and calling the doctor in the morning, I couldn’t help but think about how far we’ve come since the days when that phrase reflected what most people thought was “modern healthcare.”

TOPICS:

Ultra-small 7S Series of 7mm Incremental Rotary Encoders

June 18, 2013 4:21 pm | by MDT Staff | Product Releases | Comments

Nemicon continues to push the envelope in high-performance miniaturization with its 7S Series Incremental Rotary Encoder. At just 7.2mm in diameter, and based on Nemicon’s successful line of 18mm and 12mm diameter miniature encoders, the 7S Series shaft type encoder features high resolution, high noise immunity and high reliability.

Pressure Balanced Proportional Valve Options

June 18, 2013 4:00 pm | by Jonathan DeSousa, Division Application Engineer, Precision Fluidics Division, Parker Hannifin | Parker Hannifin Corporation | Articles | Comments

To meet the needs of today’s healthcare professionals, medical instrumentation is getting smaller and made to be portable. That means the components in them need to be smaller, while still maintaining a high level of precision. This article will look at micro valve technology in portable medical devices.

Advertisement

An Invisible Tug-of-War behind Bad Hearts and Power Outages

June 18, 2013 1:56 pm | by Morgan Kelly, Princeton University | News | Comments

Systems such as a beating heart or a power grid that depend on the synchronized movement of their parts could fall prey to an invisible and chaotic tug-of-war known as a "chimera."                     

TOPICS:

High-Voltage Devices from St. Jude Medical Get FDA Approval

June 18, 2013 1:46 pm | by St. Jude Medical | News | Comments

St. Jude Medical (NYSE:STJ) has announced U.S. Food and Drug Administration (FDA) approval of its next-generation Ellipse and SJM Assura portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds). The new devices are designed to lower the risk of lead abrasion and to ensure high-voltage therapy delivery.

TOPICS:

A Complete Interactive Patient Care Solution

June 18, 2013 1:42 pm | by Barco | News | Comments

Barco has announced the launch of “CareConnex, powered by Hospedia”, a fully integrated interactive patient care enterprise solution designed to support a better patient experience and improve hospital efficiency and profitability. 

TOPICS:

Techne to Buy Bionostics for $104M in Cash

June 18, 2013 1:37 pm | by The Associated Press | News | Comments

Techne, which makes medical testing and diagnostic products, said Tuesday that it reached a deal to buy Bionostics Holdings Ltd. and its operating subsidiary Bionostics Inc. for $104 million in cash.             

TOPICS:

Next-Gen Self-Expanding Clot Removal Device Obtains CE Mark

June 18, 2013 11:31 am | by Codman Neuro | News | Comments

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, has obtained CE marking for REVIVE SE, a next-generation self-expanding clot removal device for use in treating acute ischemic stroke.

TOPICS:
Advertisement

Safe and Effective Treatment of Large and Giant Aneurysms

June 18, 2013 11:28 am | by Covidien | News | Comments

Covidien (NYSE:COV) has announced that the final results of the PUFs (Pipeline for Uncoilable or Failed Aneurysms) clinical study of its Pipeline embolization device have been published in the June issue of Radiology.

TOPICS:

Breakthrough of Chemical Nanoengineering to Design Drugs Controlled by Light

June 18, 2013 11:19 am | by IRB Barcelona | News | Comments

The scientific cooperation between chemists, biotechnologists, and physicists from various Catalan institutes, headed by Pau Gorostiza, from the Institute for Bioengineering of Catalonia (IBEC), and Ernest Giralt, from the Institute for Research in Biomedicine (IRB Barcelona), has led to a breakthrough that will favor the development of light-regulated therapeutic molecules.

Connectors with Crimp Termination

June 18, 2013 10:46 am | by MDT Staff | Product Releases | Comments

Binder-USA has announced the addition of crimp termination to a variety of M16 connectors. Expanding the M16 product line with crimp termination will offer more options for factory production and increase productivity by simplifying assembly of the connectors.

Durable, Broad Spectrum Optics

June 18, 2013 10:34 am | by MDT Staff | Product Releases | Comments

Custom sapphire optics that are unaffected by most body fluids, acids and alkalis, transmit over a broad spectrum, and can be precision fabricated are available from Meller Optics. Meller Sapphire Optics for medical instruments are superior to most other materials because of the inherent durability of sapphire which is Moh 9 hardness...

Meters for Simple, Cost Effective Material Flow Control

June 18, 2013 9:56 am | by MDT Staff | Product Releases | Comments

TruFlow meters from Nordson enable monitoring and control of material flow during all phases and line speeds of production for nonwovens, book and product assembly, as well as for packaging applications. This variation management capability allows manufacturers to measure, understand, and improve material delivery and dispensing...

Globus Faces $16M Payment Over Patent Dispute

June 18, 2013 9:40 am | by The Associated Press | News | Comments

Spinal implant manufacturer Globus Medical may have to pay $16 million after a jury decided that three of its products infringed on the patents held by DePuy Synthes Products LLC, a unit of Johnson & Johnson Inc.                                

TOPICS:

Boston Scientific Vercise DBS System Demonstrates Improvement in Motor Function for Patients with Parkinson's Disease

June 18, 2013 12:00 am | by PR Newswire | News | Comments

Patients with Parkinson's disease using the Boston Scientific Corporation Vercise™ DBS (deep brain stimulation) System showed a significant improvement in motor scores according to interim data from the VANTAGE DBS study. The Vercise DBS System incorporates multiple independent current control, which is designed to selectively stimulate targeted areas in the brain, providing physicians with fine control of stimulation.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading